3Daian CM, Wolff AH, Bielory L, et al. The role of atypical organisms in asthma[J]. Allergy Asthma Proc, 2000,21 (2) :107-110.
4Nagayama Y,Sakuria N,Kojimas S, et al. Total and specific IgE responses in the acute and recovery phases re- spiratory infection in children [J]. J Asthma, 1987, 24: 159-164.
5Simecka JW, Patel P, Davis JK, et al. Specific and nonspecific antibody responses in different segments of the respiratory ract in rats infected with Mycoplasma palmonis[J]. Infect Immunol, 1991,59 : 3751-3755.
6Samaran samruajkit R, Jitchaiwat S, Wachirapaes W, et al . Prevalence of mycoplasma and Chlamydia pneumonia in severe community acquired pneumonia among hospital children in Thailand[J]. Jpn J Infect Dis ,2008, 61(1): 36 -39.
7Morozumi M, Lwata S, Hasegawa K, et al . Increased macrol- id resistance of mycoplasma pneumonia in pediatric patients with community acquired pneumonia[J]. Antimicrob Agents Chemother ,2008,52(1) : 348- 350.
8Cassell GH, Cole BC.Mycoplasmas agents of human disease. N Engl J Med, 1981,304 : 80-86.
9George S. Brainstem and striatal encephalitis complicating mycoplasma pneumoniae pneumonia : Possible benefit of intravenous immunoglobulin. Pediatr Infect Dis, 2001,20(5) : 543- 545.
10Kai M, Kamiya S, Yabe H, et al. Rapid detection of mycoplasma pneumoniae in clinical samples by the polymerase chain reaction.J Med Microbiol, 1992, 38(3) :166- 168.
